55513-224 : Riabni 100 mg/10ml Intravenous Injection, Solution
NDC: | 55513-224 |
Labeler: | Amgen Inc |
Product Type: | Human Prescription Drug |
Drug Name: | Riabni |
Dosage Form: | Intravenous Injection, Solution |
Application #: | BLA761140 |
Rev. Date: |
NDC Package Codes:
- 55513-224-01: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (55513‑224‑01) > 10 ML IN 1 VIAL, SINGLE‑DOSE
Active Ingredients:
- Rituximab
Dosage Strength:
- 100 mg/10mL
Pharmaceutical Classes:
- CD20-directed Antibody Interactions [MoA]
- CD20-directed Cytolytic Antibody [EPC]
Related Products:
Based on records with the same trade name.- 55513-326 Riabni 500 mg/50ml Intravenous Injection, Solution by Amgen Inc
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 55513-223Next: 55513-267 >
Related Discussions:
rituximab for rheumatoid arthritis
i am 62 yr old , suffering from rheumatoid arhtritis for the past 20 years.underwent knee replacement for both legs in 2... 1 reply
i am 62 yr old , suffering from rheumatoid arhtritis for the past 20 years.underwent knee replacement for both legs in 2... 1 reply
Mab Thera (Rituximab) for Dermatomyositus
Can dermatomyositus be cured with the drug Mab Thera (manufactured by Roche)? ## First off, I would like to state that D... 1 reply
Can dermatomyositus be cured with the drug Mab Thera (manufactured by Roche)? ## First off, I would like to state that D... 1 reply
Rituximab
RITUXIMAB) BY REDDY LAB.How effective is it for treatment of follicular lymphoma..The side effects.What is the cost of t... 1 reply
RITUXIMAB) BY REDDY LAB.How effective is it for treatment of follicular lymphoma..The side effects.What is the cost of t... 1 reply
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.